GYRE THERAPEUTICS, INC. — Institutional Ownership
Which tracked institutions hold GYRE, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
13
Funds holding
$11070038
Total value held
Buying
13 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $6550085 | 993943 | +235313 | +31.02% |
| 2 | State Street Corp | $1617199 | 245402 | +29076 | +13.44% |
| 3 | Northern Trust Corp | $1117249 | 169537 | +35696 | +26.67% |
| 4 | Goldman Sachs Group Inc | $568289 | 86235 | +13113 | +17.93% |
| 5 | Bank Of New York Mellon Corp | $413523 | 62750 | +19606 | +45.44% |
| 6 | Morgan Stanley | $274743 | 41691 | +33050 | +382.48% |
| 7 | Ubs Group Ag | $123649 | 18763 | +18763 | NEW BUY |
| 8 | Wells Fargo & Company/Mn | $107397 | 16297 | +12007 | +279.88% |
| 9 | Royal Bank Of Canada | $87000 | 13195 | +7590 | +135.41% |
| 10 | Bank Of America Corp /De/ | $82539 | 12525 | +1987 | +18.86% |
| 11 | Citigroup Inc | $56582 | 8586 | +8318 | +3103.73% |
| 12 | Jpmorgan Chase & Co | $50510 | 7831 | +2650 | +51.15% |
| 13 | Barclays Plc | $21273 | 3228 | +928 | +40.35% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.